Testing effectiveness (Phase 2)Study completedNCT02753530What this trial is testingStudy of Arimoclomol in Inclusion Body Myositis (IBM)Who this might be right forInclusion Body Myositis ZevraDenmark 152
Large-scale testing (Phase 3)Study completedNCT01165008What this trial is testingAnakinra in MyositisWho this might be right forPolymyositisDermatomyositisInclusion Body Myositis Karolinska Institutet
Not applicableStudy completedNCT03317171What this trial is testingSafety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular DystrophiesWho this might be right forMuscular DystrophiesMuscle Inflammation Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 29
Not applicableLooking for participantsNCT07374107What this trial is testingMIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)Who this might be right forIBMIIMMyositis+9 more Myositis International Health & Research Collaborative Alliance Foundation 700
Testing effectiveness (Phase 2)Study completedNCT00079768What this trial is testingAlemtuzumab to Treat Sporadic Inclusion Body MyositisWho this might be right forMyositis, Inclusion Body National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableEnrolling By InvitationNCT07072676What this trial is testingThe Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.Who this might be right forInclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more LMU Klinikum 30
Large-scale testing (Phase 3)Study completedNCT02250443What this trial is testingStudy of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body MyositisWho this might be right forSporadic Inclusion Body Myositis (sIBM) Novartis Pharmaceuticals 10
Post-approval studies (Phase 4)Study completedNCT06133751What this trial is testingEffect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained RowersWho this might be right forInflammation;Muscle(S)Oxidative Stress InjuryPermeability; Increased Poznan University of Physical Education 15
Not applicableActive Not RecruitingNCT01171573What this trial is testingInvestigating Genes in Patients With Polymyositis and DermatomyositisWho this might be right forMyositis Northern Care Alliance NHS Foundation Trust 1,000
Testing effectiveness (Phase 2)Study completedNCT00805870What this trial is testingThe Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory MarkersWho this might be right forMuscle DamageMuscle Inflammation Western Michigan University 20
Not applicableStudy completedNCT04907162What this trial is testingMusculoskeletal Nociceptive Pain in Participants With Neuromuscular DisordersWho this might be right forPompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more LMU Klinikum 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06450886What this trial is testingLong-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body MyositisWho this might be right forInclusion Body Myositis (IBM) Abcuro, Inc. 270
Large-scale testing (Phase 3)Study completedNCT05721573What this trial is testingEvaluate the Efficacy and Safety of ABC008 for Inclusion Body MyositisWho this might be right forInclusion Body Myositis Abcuro, Inc. 272
Large-scale testing (Phase 3)Study completedNCT02481453What this trial is testingRapamycine vs Placebo for the Treatment of Inclusion Body MyositisWho this might be right forInclusion Body Myositis (IBM) Institut National de la Santé Et de la Recherche Médicale, France 44
Very early researchLooking for participantsNCT06479863What this trial is testingEfficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body MyositisWho this might be right forSporadic Inclusion Body Myositis (sIBM)Idiopathic Inflammatory Myopathies Austin Neuromuscular Center 10
Early research (Phase 1)UnknownNCT02483845What this trial is testingNatalizumab in Inclusion Body Myositis (IBM)Who this might be right forInclusion Body Myositis (IBM) Phoenix Neurological Associates, LTD 6
Not applicableEnrolling By InvitationNCT06605612What this trial is testingDevelopment and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular DisordersWho this might be right forInclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more LMU Klinikum 108
Not applicableStudy completedNCT01734369What this trial is testingEnvironmental Risk Factors for Myositis in Military PersonnelWho this might be right forDermatomyositisAdult PolymyositisInclusion Body Myositis+1 more National Institute of Environmental Health Sciences (NIEHS) 37
Early research (Phase 1)UnknownNCT05032131What this trial is testingCell Therapy for IBM by Muscle Injection of ADSVFWho this might be right forInclusion Body Myositis Assistance Publique - Hôpitaux de Paris 32
Not applicableStudy completedNCT05880030What this trial is testingThe Effect of Supplementation of Vitamin D3 on Inflammation Induced by 100 km Running, Iron Metabolism and ErythropoiesisWho this might be right forInflammation; MuscleIron MetabolismIneffective Erythropoiesis+1 more Gdansk University of Physical Education and Sport 40